These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 6307716)

  • 1. Calcium antagonists and calmodulin: effect of verapamil, nifedipine and diltiazem.
    Daly MJ; Perry S; Nayler WG
    Eur J Pharmacol; 1983 May; 90(1):103-8. PubMed ID: 6307716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Verapamil, diltiazem and nifedipine interactions with calmodulin stimulated (Ca2+ + Mg2+)-ATPase.
    Kim HC; Raess BU
    Biochem Pharmacol; 1988 Mar; 37(5):917-20. PubMed ID: 2964236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ca(2+)-channel blockers and nucleoside triphosphate diphosphohydrolase (NTPDase) influence of diltiazem, nifedipine, and verapamil.
    Gendron FP; Latour JG; Gravel D; Wang Y; Beaudoin AR
    Biochem Pharmacol; 2000 Dec; 60(12):1959-65. PubMed ID: 11108813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential antagonism by Bay k 8644, a dihydropyridine calcium agonist, of the negative inotropic effects of nifedipine, verapamil, diltiazem and manganese ions in canine ventricular muscle.
    Ishii K; Taira N; Yanagisawa T
    Br J Pharmacol; 1985 Feb; 84(2):577-84. PubMed ID: 2579702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calmodulin-stimulated plasma membrane (Ca2+ + Mg2+)-ATPase: inhibition by calcium channel entry blockers.
    Raess BU; Gersten MH
    Biochem Pharmacol; 1987 Aug; 36(15):2455-9. PubMed ID: 3038124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium channel blocker inhibition of the calmodulin-dependent effects of thyroid hormone and milrinone on rabbit myocardial membrane Ca2+-ATPase activity.
    Warnick PR; Davis FB; Mylotte KM; Davis PJ; Dube MP; Blas SD
    Biochem Pharmacol; 1988 Jul; 37(13):2619-23. PubMed ID: 2968801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection by Ca2+ channel blockers (nifedipine, diltiazem and verapamil) against the toxicity of oxidized low density lipoprotein to cultured lymphoid cells.
    Nègre-Salvayre A; Salvayre R
    Br J Pharmacol; 1992 Nov; 107(3):738-44. PubMed ID: 1472971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of various L-type and T-type calcium antagonists on electrically generated, potassium-induced and carbachol-induced contractions of porcine detrusor muscle.
    Badawi JK; Li H; Langbein S; Kamp S; Guzman S; Bross S
    J Comp Physiol B; 2006 Jun; 176(5):429-39. PubMed ID: 16425017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitor effects of diltiazem, nicardipine, nifedipine and verapamil on the norepinephrine-induced contractions of the canine saphenous vein in calcium-free medium.
    Saïag B; Milon D; Bentue-Ferrer D; Allain H; Rault B; Van den Driessche J
    Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):255-69. PubMed ID: 8008975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anticholinesterase effect of calcium channel blockers: diltiazem, verapamil, and nifedipine].
    Ivanov IuIa
    Dokl Akad Nauk; 1998 Mar; 359(3):413-4. PubMed ID: 9608914
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of nifedipine, verapamil, diltiazem and trifluoperazine on the antinociceptive activity of acetaminophen.
    Koleva M; Dimova S
    Methods Find Exp Clin Pharmacol; 2000 Dec; 22(10):741-5. PubMed ID: 11346895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study on calcium channel antagonists in the human radial artery: clinical implications.
    He GW; Yang CQ
    J Thorac Cardiovasc Surg; 2000 Jan; 119(1):94-100. PubMed ID: 10612766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibited neutrophil functions in patients treated with nifedipine but not with verapamil or diltiazem.
    Levy R; Nagauker-Shriker O; Schlaeffer F
    Eur J Clin Invest; 1996 May; 26(5):376-81. PubMed ID: 8796364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential actions of calcium antagonists on calcium binding to cardiac sarcolemma.
    Pang DC; Sperelakis N
    Eur J Pharmacol; 1982 Jul; 81(3):403-9. PubMed ID: 6981516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The haemodynamic effects of nifedipine, verapamil and diltiazem in patients with coronary artery disease. A review.
    Soward AL; Vanhaleweyk GL; Serruys PW
    Drugs; 1986 Jul; 32(1):66-101. PubMed ID: 2874975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential cardiovascular effects of calcium channel blocking agents: potential mechanisms.
    Millard RW; Lathrop DA; Grupp G; Ashraf M; Grupp IL; Schwartz A
    Am J Cardiol; 1982 Feb; 49(3):499-506. PubMed ID: 6277175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of hypoxia, elevated K+ and acidosis on the potency of verapamil, diltiazem and nifedipine in the guinea-pig isolated papillary muscle.
    Robertson MJ; Lumley P
    Br J Pharmacol; 1989 Nov; 98(3):937-49. PubMed ID: 2590774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of calcium channel blockers on isoproterenol induced cyclic adenosine 3',5'-monophosphate generation in intact human lymphocytes.
    Hui KK; Yu JL
    Life Sci; 1988; 42(20):2037-45. PubMed ID: 2452949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium-channel blocking agents.
    Leonard RG; Talbert RL
    Clin Pharm; 1982; 1(1):17-33. PubMed ID: 6764159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.